The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.

Rep. Mike Collins (R-Ga.) heavily criticized statements made by the Right Rev. Mariann Budde on Tuesday at the inaugural ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

"Spravato" can be used on its own by people who don't respond to traditional depression medication. Against the odds, Prince ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.

The FDA approved Spravato for those battling depression and has seen little to no improvement from two types of ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...